Literature DB >> 10476752

Influence of environmental temperature on incidence of indinavir-related nephrolithiasis.

E Martínez1, M Leguizamón, J Mallolas, J M Miró, J M Gatell.   

Abstract

We analyzed the influence of temperature, humidity, and atmospheric pressure on the 1-year incidence of nephrolithiasis among human immunodeficiency virus type 1-infected patients treated with indinavir. One hundred three patients (13.6%) developed 326 episodes of nephrolithiasis. Eighty-two patients (79.6%) had more than one episode (range, two to seven episodes). The overall incidence ranged from 0 to 10.2 episodes per 100 patients exposed per month. There was a significant correlation between temperature and the overall incidence of nephrolithiasis and the incidence of recurrences but not with the incidence of first episodes. Nephrolithiasis was not related to humidity or atmospheric pressure. Our data support the standard recommendation of drinking at least 1.5 L of water daily to prevent nephrolithiasis in most patients treated with indinavir irrespective of meteorologic factors. However, the risk of nephrolithiasis is higher for a certain subgroup of patients when the environment is hot irrespective of adequate water intake.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10476752     DOI: 10.1086/520226

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  Modeling the distribution of urolithiasis prevalence under projected climate change in Iran.

Authors:  Ahmad Shajari; Mohammad Mousaei Sanjerehei
Journal:  Urolithiasis       Date:  2015-05-15       Impact factor: 3.436

Review 2.  Drug-Induced Kidney Stones and Crystalline Nephropathy: Pathophysiology, Prevention and Treatment.

Authors:  Michel Daudon; Vincent Frochot; Dominique Bazin; Paul Jungers
Journal:  Drugs       Date:  2018-02       Impact factor: 9.546

3.  Improving data reliability using a non-compliance detection method versus using pharmacokinetic criteria.

Authors:  Smita A Kshirsagar; Terrence F Blaschke; Lewis B Sheiner; M Krygowski; Edward P Acosta; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-09-27       Impact factor: 2.745

4.  Renal Dysfunction in HIV-1-infected Patients.

Authors:  Jeffrey B. Kopp
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

Review 5.  Drug-induced renal calculi: epidemiology, prevention and management.

Authors:  Michel Daudon; Paul Jungers
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 6.  Renal effects of non-tenofovir antiretroviral therapy in patients living with HIV.

Authors:  Milena M McLaughlin; Aimee J Guerrero; Andrew Merker
Journal:  Drugs Context       Date:  2018-03-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.